Abstract:Diabetic nephropathy (DN) is a common and serious microvascular complication of diabetes mellitus (DM). According to epidemiological studies, more than 425 million people worldwide are currently affected by diabetes. If no action is taken, more and more people with diabetes worldwide will rise to 629 million by 2045. [ 1 ] As the prevalence of diabetes has increased, the incidence of DN has increased rapidly. Being expected to 30% to 40% of diabetic patients develop DN, finally, the one third of DN patients develop end-stage renal disease. Currently, it has been shown that the mechanism of DN is the result of a combination of factors such as glucose metabolism disorders, changes in glomerular hemodynamics, inflammatory reactions, cytokines, endothelial damage, oxidative stress, ischemia and hypoxia, and genetic susceptibility. Chronic renal hypoxia, caused by various factors such as hyperglycemia, endothelial damage, and inflammatory responses, is one of the main causes of the occurrence and development of DN. Hypoxia is considered as an etiological factor in the progression of renal injury. HIF1α is a major transcription factor that transduces an array of cellular processes to let the cells adapt to hypoxic injury. Therefore, a sustained increase in HIF1α is a major adaptive stimulus to the hypoxic conditions. [ 2 ] By regulating its target ZEB2 gene (Zinc finger E-box-binding homeobox 2), it affects pathological and physiological processes such as glucose, energy metabolism, inflammation, and plays an essential role in the occurrence and development of DN. [ 3–5 ] There is a growing body of evidence that hypoxia can cause kidney damage, inflammatory reactions, loss of podocytes and abnormal function, and reduced glomerular filtration rates leading to proteinuria. If not intervened in a timely manner at an early stage, this is a huge financial burden on society. [ 6 ] Western medications are used to treat DN by regulating blood glucose, blood lipid levels and blood pressure. Early medical studies have shown that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (angiotensin II receptor blockers) as first-line treatment for DN can reduce proteinuria, The role of delaying the progress of renal dysfunction. [ 7 ] However, the side effects of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers limit the use of these drugs. Therefore, the search for safe and effective therapies for DN is of great urgency.

Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo

Crocin Inhibited Epithelial-Mesenchymal Transition in Renal Tubular Epithelial Cells to Treat Diabetic Nephropathy Through Improving AMPK/mTOR-Mediated Autophagy

Sinomenine Alleviates High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the Activation of RhoA/ROCK Signaling Pathway.

Danshen Injection Ameliorates STZ-induced Diabetic Nephropathy in Association with Suppression of Oxidative Stress, Pro-Inflammatory Factors and Fibrosis

ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte

High‐dose sinomenine attenuates ischemia/reperfusion‐induced hepatic inflammation and oxidative stress in rats with diabetes mellitus

Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3 Β/β-Catenin Pathway by Restoring Autophagic Activity

Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy

Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation

Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation

Sinomenine Activation of Nrf2 Signaling Prevents Hyperactive Inflammation and Kidney Injury in a Mouse Model of Obstructive Nephropathy.

Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis

CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy

Sinomenine Attenuates Renal Fibrosis Through Nrf2-mediated Inhibition of Oxidative Stress and TGFβ Signaling

Genipin Inhibits Mitochondrial Uncoupling Protein 2 Expression And Ameliorates Podocyte Injury In Diabetic Mice

Tanshinone IIA Promoted Autophagy and Inhibited Inflammation to Alleviate Podocyte Injury in Diabetic Nephropathy

Shengqing Jiangzhuo capsule ameliorates diabetic nephropathy by improving Keap1/Nrf2 signaling pathway

Downregulation of Salusin-β protects renal tubular epithelial cells against high glucose-induced inflammation, oxidative stress, apoptosis and lipid accumulation via suppressing miR-155-5p

Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC‐1α mediated attenuation of mitochondrial oxidative stress

Tangshen Decoction Enhances Podocytes Autophagy to Relieve Diabetic Nephropathy through Modulation of p-AMPK/p-ULK1 Signaling

Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation